Loading stock data…
BEIERSDORF AG I (BEI.DE)
€76.44+0.84 (+1.11%)
Market ClosedLast close Sep 8
Beiersdorf Aktiengesellschaft, together with its subsidiaries, manufactures and distributes consumer goods in Europe, the United States, Africa, Asia, and Australia.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
BEI.DE in the Consumer Defensive sector is trading at €76.44 with a market capitalization of $17.1B. Wall Street consensus targets €82.11 (19 analysts), implying a +7.4% move over the next 12 months. The stock is currently 31% below its 52-week high of €110.15, remaining 7.3% below its 200-day moving average. Risk note: MACD remains below its signal line. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +7.4% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Annual Financials
| Metric (EUR) · Annual | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Total Revenue | €8.80B↓ | €9.45B↓ | €9.85B | €9.85B |
| Gross Profit | €4.96B↓ | €5.42B↓ | €5.76B↑ | €5.69B |
| Operating Income | €1.20B↑ | €1.17B↓ | €1.34B↓ | €1.36B |
| Net Income | €755.00M↑ | €736.00M↓ | €912.00M↓ | €939.00M |
Peer Comparison
Fundamentals
Beiersdorf Aktiengesellschaft, together with its subsidiaries, manufactures and distributes consumer goods in Europe, the United States, Africa, Asia, and Australia. The company operates through two segments: Consumer Business and Tesa Business. The ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
€17.08B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
18.21
Beta
Defensive asset. Lower volatility than the S&P 500.
0.49
Div Yield
Strong income play. Yield provides a meaningful total return floor.
127.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
10.89%
Volume
Today's trading volume
279,115
Recent News
Beiersdorf Aktiengesellschaft Q2 Earnings Call Highlights
Beiersdorf Aktiengesellschaft (ETR:BEI) reported a weaker first half of 2026 as continued pressure at NIVEA outweighed growth in its Derma and Healthcare businesses. The company lowered its full-year outlook for its consumer segment and group sales, while outlining an 18-month plan intended to resto
Assessing Beiersdorf (XTRA:BEI) Valuation After Recent Share Price Weakness
Assessing recent performance for Beiersdorf Beiersdorf (XTRA:BEI) has been under pressure recently, with the stock showing negative returns over the past month and past 3 months, as well as over the past year. For investors, this weaker share performance sits alongside annual revenue of €9.85b and net income of €939m. This raises questions about how the current valuation reflects the company’s consumer and industrial exposure. See our latest analysis for Beiersdorf. Beiersdorf’s share price...
Beiersdorf AGM: NIVEA Reset, €750M Buyback Unveiled as 2026 Outlook Turns Cautious
Beiersdorf Aktiengesellschaft (ETR:BEI) executives used the company’s 2026 annual general meeting to outline a strategic reset for its core NIVEA brand, defend capital allocation priorities including a new share buyback program, and highlight innovation initiatives ranging from pigmentation treatmen
Beiersdorf AG (BDRFF) Q1 2026 Earnings Call Highlights: Navigating Sales Declines and Strategic ...
Despite a challenging quarter with overall sales declines, Beiersdorf AG (BDRFF) remains optimistic about future growth driven by strong performance in its Derma segment and strategic initiatives.
Beiersdorf Aktiengesellschaft Q1 Earnings Call Highlights
Beiersdorf Aktiengesellschaft (ETR:BEI) reported a challenging start to 2026 but said results were broadly in line with expectations, supported by continued strength in its Derma business and improving sell-out trends despite weak first-quarter net sales. On the company’s Q1 2026 conference call, C